Literature DB >> 12107359

Acquisition and review of non-U.S.-based HIV risk reduction intervention studies.

Agatha Eke1, Greet Peersman, Salaam Semaan, Kevin Hylton, Ndunge Kiiti, Michael D Sweat.   

Abstract

In response to the HIV/AIDS epidemic, many governments and nongovernmental organizations have supported numerous HIV prevention intervention studies in both the United States and in other countries. To understand which intervention approaches have worked outside the United States, the Centers for Disease Control and Prevention extended the scope of its HIV/AIDS Prevention Research Synthesis (PRS) project to include non-U.S.-based studies. We describe briefly the PRS experience with the challenges of acquiring and reviewing those studies, and some of the specialized efforts to find them. The ultimate goals of the PRS project related to international prevention research are to include all available reports of non-U.S.-based studies in the PRS database and to provide comprehensive reviews of those studies. The findings of the reviews would not only highlight common themes of effectiveness or research gaps in the international arena but could also be useful for improving prevention research and programs in the United States.

Entities:  

Mesh:

Year:  2002        PMID: 12107359

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

1.  Effectiveness trial of community-based I Choose Life-Africa human immunodeficiency virus prevention program in Kenya.

Authors:  Mary B Adam
Journal:  Am J Trop Med Hyg       Date:  2014-06-23       Impact factor: 2.345

2.  The Global HIV Archive: Facilitating the Transition from Science to Practice of Efficacious HIV Prevention Interventions.

Authors:  Josefina J Card; Emily N Newman; Rachel E Golden; Tamara Kuhn; Carmela Lomonaco
Journal:  World J AIDS       Date:  2013-03

3.  Research Synthesis, HIV Prevention Response, and Public Health: CDC's HIV/AIDS Prevention Research Synthesis Project.

Authors:  Linda J Koenig; Cynthia M Lyles; Darrel Higa; Mary M Mullins; Theresa A Sipe
Journal:  Public Health Rep       Date:  2021-02-26       Impact factor: 2.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.